Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe pers...

Por Beeh, Kai-Michael, LaForce, Craig, Gahlemann, Martina, Wenz, Arne, Toorawa, Robert, Fležar, Matjaž
Publicado no Respir Res (2015)

Randomized, Double-Blind, Placebo-Controlled, Safety and Immunogenicity Study of 4 Formulations...

Por Hopkins, Robert J., Daczkowski, Nancy F., Kaptur, Paulina E., Muse, Derek, Sheldon, Eric, LaForce, Craig, Sari, Suha, Rudge, Thomas L., Bernton, Edward
Publicado em 2013

Investigation of Different Group A Immunoassays following One Dose of Meningococcal Group A Conjugate Vaccine or A/C Polysaccharide Vaccine in Adults

Por Findlow, H., Plikaytis, B. D., Aase, A., Bash, M. C., Chadha, H., Elie, C., Laher, G., Martinez, J., Herstad, T., Newton, E., Viviani, S., Papaspyridis, C., Kulkarni, P., Wilding, M., Preziosi, M. P., Marchetti, E., Hassan-King, M., La Force, F. M., Carlone, G., Borrow, R.
Publicado em 2009

An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)

Por Gotfried, Mark H., Girod, Carlos E., Antin-Ozerkis, Danielle, Burgess, Tracy, Strombom, Indiana, Stauffer, John L., Kirchgaessler, Klaus-Uwe, Padilla, Maria L.
Publicado no Pulm Ther (2018)

Novel soft-start method for three-phase voltage source rectifier based on virtual resistor control

Por Kaizhong He, Hongsheng Su
Publicado em 2020-03-01

Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses

Por Uhl, Wolfgang, Zühlsdorf, Michael, Koernicke, Thomas, Forssmann, Ulf, Kovar, Andreas
Publicado em 2013

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

Por Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Publicado no Invest New Drugs (2019)

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics

Por Nwankwo, Nwabundo, Zhang, Zhe, Wang, Ting, Collins, Connie, Resta, Lee, Ermisch, Sabine, Day, Jeannette, Decker, Rodney, Kornberg, Lori, Nicol, Steven, Thornton, Donald, Armstrong, Deborah K., Carducci, Michael A.
Publicado em 2012

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

Por Baas, J. M., Krens, L. L., ten Tije, A. J., Erdkamp, F., van Wezel, T., Morreau, H., Gelderblom, H., Guchelaar, H. J.
Publicado no Invest New Drugs (2015)

A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous...

Por Williams, Brent A., Law, Arjun Datt, Routy, Bertrand, denHollander, Neal, Gupta, Vikas, Wang, Xing-Hua, Chaboureau, Amélie, Viswanathan, Sowmya, Keating, Armand
Publicado no Oncotarget (2017)

Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study

Por Chabriat, Hugues, Bassetti, Claudio L., Marx, Ute, Picarel-Blanchot, Françoise, Sors, Aurore, Gruget, Celine, Saba, Barbara, Wattez, Marine, Audoli, Marie-Laure, Hermann, Dirk M.
Publicado no Trials (2020)

Efficacy and Safety of Artemether in the Treatment of Chronic Fascioliasis in Egypt: Exploratory Phase-2 Trials

Por Keiser, Jennifer, Sayed, Hanan, El-Ghanam, Maged, Sabry, Hoda, Anani, Saad, El-Wakeel, Aly, Hatz, Christoph, Utzinger, Jürg, el-Din, Sayed Seif, El-Maadawy, Walaa, Botros, Sanaa
Publicado em 2011

Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies

Por Kusawake, Tomohiro, Keirns, James J., Kowalski, Donna, den Adel, Martin, Groenendaal-van de Meent, Dorien, Takada, Akitsugu, Ohtsu, Yoshiaki, Katashima, Masataka
Publicado no Adv Ther (2017)

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients...

Por Beier, Jutta, Kirsten, Anne-Marie, Mróz, Robert, Segarra, Rosa, Chuecos, Ferran, Caracta, Cynthia, Gil, Esther Garcia
Publicado em 2013

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients...

Por Burock, Susen, Daum, Severin, Keilholz, Ulrich, Neumann, Konrad, Walther, Wolfgang, Stein, Ulrike
Publicado no BMC Cancer (2018)

Efficacy and safety of ozonated autohemotherapy in patients with hyperuricemia and gout: A phase I pilot study

Por LI, LIAN-YUN, NI, JIA-XIANG
Publicado em 2014

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Por Suhr, Ole B, Coelho, Teresa, Buades, Juan, Pouget, Jean, Conceicao, Isabel, Berk, John, Schmidt, Hartmut, Waddington-Cruz, Márcia, Campistol, Josep M., Bettencourt, Brian R., Vaishnaw, Akshay, Gollob, Jared, Adams, David
Publicado no Orphanet J Rare Dis (2015)

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease

Por Egan, Michael F., Mukai, Yuki, Voss, Tiffini, Kost, James, Stone, Julie, Furtek, Christine, Mahoney, Erin, Cummings, Jeffrey L., Tariot, Pierre N., Aisen, Paul S., Vellas, Bruno, Lines, Christopher, Michelson, David
Publicado no Alzheimers Res Ther (2019)

Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD...

Por Saka, Hideo, Kitagawa, Chiyoe, Kogure, Yoshihito, Takahashi, Yasuo, Fujikawa, Koshi, Sagawa, Tamotsu, Iwasa, Satoru, Takahashi, Naoki, Fukao, Taro, Tchinou, Catherine, Landers, Dónal, Yamada, Yasuhide
Publicado no Invest New Drugs (2017)